NCT06693323View on ClinicalTrials.gov

Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 4, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
HNSCCHead and Neck Squamous Cell Carcinoma
Interventions
DRUG

AHCC®capsules

Given PO

Trial Locations (1)

92868

RECRUITING

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER